Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today launched the cfDNA Library Preparation Kit to enable liquid biopsy research. Liquid biopsies have gained prominence in critical applications such as cancer screening,…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks